美国创新药注册沟通交流机制研究启示——以索托拉西布为例

美国创新药注册沟通交流机制研究启示——以索托拉西布为例

China Food Drug Administration ›› 2023, Vol. 0 ›› Issue (9) : 114-121.

PDF(1378 KB)

PDF(1378 KB)

China Food Drug Administration ›› 2023, Vol. 0 ›› Issue (9) : 114-121. DOI: 10.3969/j.issn.1673-5390.2023.09.014

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1378 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉